Spot the difference: genomic sub-types of leukaemia
Recent genetic analysis exposes differences in blood cancer, offering hope for patients and the future of personalised medicine
Cancer is, essentially, a genetic disease – caused by the accumulation of mutations in a cell’s DNA that allow it to evade the normal controls over how, when and where it can multiply and specialise. The advent of affordable genome sequencing means that oncology and haematology are rapidly evolving as our understanding of cancer grows; the ultimate goal is better treatments, though tools to improve risk prediction or provide earlier and more precise diagnosis and prognosis are also highly valuable.
No hay comentarios:
Publicar un comentario